InvestorsHub Logo
Followers 2
Posts 27
Boards Moderated 0
Alias Born 07/09/2009

Re: Stock_Barber post# 61155

Monday, 09/01/2014 9:45:23 PM

Monday, September 01, 2014 9:45:23 PM

Post# of 130743
I think Stock Barber's statement has to be taken into consideration. People are really excited and going overboard here.

Its great that we have a deal with one of the leader in contact lenses. We have to take it into account that the market for contact lenses worldwide is only $7 Billion where the following are the major market share.

Johnson & Johnson - 40%
Ahlcon - 20%
Coopervision - 20+%
Bosch&Lamb-10+%

Considering all the data which is available i think EPGL is already overvalued with 300m market cap.

I still think EPGL technology is a game changer for COO to increase its market share but still we have to wait and see how this partnership turns out into revenues for EPGL.

Does anyone remember RXII which is once a OTC company had a great partnership with Genentech for its RNAi technology. It is currently trading in nasdaq and has only $50 million dollar market cap.

Partnership with the great company validates the company's credibility but doesn't always turn a Pink/OTC company to have a higher market cap.

I'll still hold and wait to see what in unfolds. I hope i can see $0.25 in couple of years






Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.